NME5
Nucleoside diphosphate kinase homolog 5
Also known as: NDK5_HUMAN, nm23-H5, RSPH23
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56597
- Gene
- NME5
- Ensembl
- ENSG00000112981
- Chromosome
- 5
- Canonical length
- 212 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Primary cilium,Cytosol
OverviewNCBI Gene
Enables 3'-5' exonuclease activity. Involved in spermatid development. Predicted to be located in 9+2 motile cilium. Predicted to be part of radial spoke. Predicted to be active in cilium. Implicated in primary ciliary dyskinesia. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
212 residues, UniProt reviewed canonical sequence.
>P56597|NME5
1 MEISMPPPQI YVEKTLAIIK PDIVDKEEEI QDIILRSGFT IVQRRKLRLS PEQCSNFYVE
61 KYGKMFFPNL TAYMSSGPLV AMILARHKAI SYWLELLGPN NSLVAKETHP DSLRAIYGTD
121 DLRNALHGSN DFAAAEREIR FMFPEVIVEP IPIGQAAKDY LNLHIMPTLL EGLTELCKQK
181 PADPLIWLAD WLLKNNPNKP KLCHHPIVEE PYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NME5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- testis: 50 nTPM
- fallopian tube: 35 nTPM
- choroid plexus: 28 nTPM
- parathyroid gland: 23 nTPM
- epididymis: 22 nTPM
- kidney: 19 nTPM
Single-cell type
- late primary spermatocytes: 1,078 nCPM
- early spermatids: 648 nCPM
- respiratory ciliated cells: 408 nCPM
- late spermatids: 351 nCPM
- fallopian tube ciliated cells: 333 nCPM
- ependymal cells: 328 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 29 nTPM
- midbrain: 15 nTPM
- medulla oblongata: 15 nTPM
- thalamus: 12 nTPM
- basal ganglia: 10 nTPM
- cerebral cortex: 10 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NME5.
Disease | AllUniProt
Conditions NME5 is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 48, without situs inversus (CILD48) MIM:620032
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 36 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ciliary dyskinesia, primary, 48, without situs inversus
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- cilium movement
- CTP biosynthetic process
- DNA catabolic process
- epithelial cilium movement involved in extracellular fluid movement
- establishment of localization in cell
- GTP biosynthetic process
- negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
- nucleoside metabolic process
- spermatid development
- spermatogenesis
- UTP biosynthetic process
- ventricular system development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NME5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NME5 as an antibody target. Whether an autoantibody or antibody against NME5 could matter depends on whether native NME5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NME5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NME5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...